MannKind Corporation
Heat-stable dry powder pharmaceutical compositions and methods

Last updated:

Abstract:

Disclosed herein are heat-stable dry powders which include peptides or protein such as oxytocin for use as a pharmaceutical composition. The composition is highly stable at increased temperatures and relatively high humid environments, and are intended for storage at room temperature with an improved shelf-life. In particular, the dry powders are intended for inhalation, however, other routes of administration can be used when reconstituted in solution.

Status:
Grant
Type:

Utility

Filling date:

1 Aug 2019

Issue date:

25 May 2021